首页 › 基金 › PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. › RPRX

PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 对 RPRX 的持仓历史

ROYALTY PHARMA PLC · 医疗保健

PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 在 Q3 2026 的 13F 申报中披露持有 RPRX(ROYALTY PHARMA PLC)510,625 股,市值约 US$29.8M,约占其申报组合的 1.51%,在其申报持仓中市值排名第 17 位。 PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 最近 11 个申报季度中有 11 个季度披露了 RPRX 持仓,最早可追溯至 Q1 2024。

最新持仓 (Q3 2026)510.62K 股
申报持仓市值$29.80M
组合权重1.51%
首次申报Q1 2024
最近变动减持
更新于2026-11-16

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 对 RPRX 的持仓演变

PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 于 Q1 2024 首次披露 RPRX 持仓:368,916 股(约 US$11.2M)。 该持仓在 Q2 2026 达到峰值 597,938 股,市值约 US$33.5M。 在 11 次申报中,PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 6 次增持、1 次减持、3 次保持不变。 最近一期申报(Q3 2026)显示持股 510,625 股、市值约 US$29.8M,环比减持 -87,313 股。。

逐季持仓明细

季度股数金额变化
Q1 2024 368.92K $11.20M 新进
Q2 2024 424.54K $11.20M 增持
Q3 2024 461.05K $13.04M 增持
Q4 2024 472.21K $12.05M 增持
Q1 2025 573.60K $17.86M 增持
Q2 2025 595.96K $21.47M 增持
Q3 2025 595.89K $21.02M 持有
Q4 2025 600.17K $23.19M 增持
Q1 2026 598.62K $28.72M 持有
Q2 2026 597.94K $33.53M 持有
Q3 2026 510.62K $29.80M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 RPRX 与 13F 数据

RPRX(ROYALTY PHARMA PLC)属于医疗保健行业。我们追踪的基金中还有 47 只申报持有 RPRX,申报仓位最大的包括:Swedbank AB (US$598.8M), Baillie Gifford (US$534.1M), ROYAL LONDON ASSET MANAGEMENT LTD (US$348.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 RPRX 的基金

查看 RPRX 的全部基金持有人 →

常见问题

How long has PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. held RPRX?

PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. has disclosed RPRX holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.'s current position in RPRX?

As of Q3 2026, PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. holds 510.62K shares of RPRX (ROYALTY PHARMA PLC), valued at $29.80M, representing 1.51% of its reported portfolio and ranking #17.

Has PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. been buying or selling RPRX?

In the latest 13F filing (Q3 2026), PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. reduced its position in RPRX. The position peaked in Q2 2026 at 597.94K shares.

Which other funds hold RPRX?

Other major institutional holders of RPRX include Swedbank AB, Baillie Gifford, ROYAL LONDON ASSET MANAGEMENT LTD, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.